Morgan Gonder
Pain Medicine · Lees Summit, MONPI 1902390784
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by Abbott at 44.4% of the total. Reporting peaked in 2023 at $3,293 and has fallen 92.8% since, to $236 in 2025.
Across 67 payments — averaging $83.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Stryker$935
- Boston Scientific$298
- Nevro Corp.$272
- MML US, Inc.$263
- Vertos Medical, Inc.$228
- plus $1K from 11 others
What the payments were for
- Travel & lodging$2,44844%
- Food & beverage$3,11556%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 25 | $2,470 |
| Stryker | 7 | $935 |
| Boston Scientific | 2 | $298 |
| Nevro Corp. | 4 | $272 |
| MML US, Inc. | 7 | $263 |
| Vertos Medical, Inc. | 1 | $228 |
| Nalu Medical, Inc. | 5 | $214 |
| Bioventus LLC | 2 | $174 |
| Relievant Medsystems, Inc. | 1 | $168 |
| Terumo Medical Corporation | 1 | $141 |
| Averitas Pharma Inc. | 1 | $114 |
| SPR Therapeutics, Inc | 4 | $104 |
| Medtronic | 3 | $95 |
| Saluda Medical Americas, Inc. | 1 | $27 |
| Tonix Medicines, Inc. | 1 | $24 |
| Olympus America Inc. | 1 | $19 |
| Titan Surgical Group, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$1,704
- AUGMENT INJECTABLE$734
- Intracept$673
- mild Device Kit$228
- Senza$225
- OCTRODE$156
- GlideWire$141
- HydroPearl$141
- Azur CX Detachable$141
- GENERAL PAIN MANAGEMENT$138
- ReActiv8$129
- Stimrouter Implantable Kit$122
- Nalu Neurostimulation System$114
- Qutenza$114
How this compares
$5,563 in reported general payments places this provider in the 70th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 142 | $3,254 |
| Celecoxib | 15 | $663 |
| Gabapentin | 90 | $614 |
| Baclofen | 56 | $548 |
| Duloxetine Hcl | 43 | $497 |
| Methocarbamol | 48 | $240 |
| Cyclobenzaprine Hcl | 20 | $185 |
| Meloxicam | 38 | $57 |
| Tramadol Hcl | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Lees Summit
- Nicholas DonohueLees Summit$15K
- James ScowcroftLees Summit$7K
- Joel AckermanLees Summit$5K
- Mark ChaplickLees Summit$4K
- Jarron TilghmanLees Summit$4K
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.